ES520358A0 - Procedimiento para producir polipeptido - Google Patents

Procedimiento para producir polipeptido

Info

Publication number
ES520358A0
ES520358A0 ES520358A ES520358A ES520358A0 ES 520358 A0 ES520358 A0 ES 520358A0 ES 520358 A ES520358 A ES 520358A ES 520358 A ES520358 A ES 520358A ES 520358 A0 ES520358 A0 ES 520358A0
Authority
ES
Spain
Prior art keywords
procedure
class
producing polypeptide
exploitation
discovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES520358A
Other languages
English (en)
Other versions
ES8500327A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8500327A1 publication Critical patent/ES8500327A1/es
Publication of ES520358A0 publication Critical patent/ES520358A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
ES520358A 1982-03-08 1983-03-07 Procedimiento para producir polipeptido Granted ES520358A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35529882A 1982-03-08 1982-03-08
US43812882A 1982-11-01 1982-11-01

Publications (2)

Publication Number Publication Date
ES8500327A1 ES8500327A1 (es) 1984-11-01
ES520358A0 true ES520358A0 (es) 1984-11-01

Family

ID=26998783

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520358A Granted ES520358A0 (es) 1982-03-08 1983-03-07 Procedimiento para producir polipeptido
ES533485A Expired ES8605534A1 (es) 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES533485A Expired ES8605534A1 (es) 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable.

Country Status (17)

Country Link
EP (1) EP0088622B1 (es)
JP (4) JP2633227B2 (es)
AT (1) ATE123813T1 (es)
AU (1) AU572447B2 (es)
CA (1) CA1339936C (es)
DD (1) DD207732A5 (es)
DE (2) DE3382789T2 (es)
DK (1) DK171790B1 (es)
ES (2) ES520358A0 (es)
FR (1) FR2530662B1 (es)
GB (1) GB2116566B (es)
IE (1) IE54592B1 (es)
IL (1) IL68059A (es)
NZ (1) NZ203493A (es)
PL (1) PL153902B1 (es)
PT (1) PT76353B (es)
YU (1) YU46722B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
WO1984003300A1 (en) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Leukocytic human interferon n and method to obtain it in bacterial cells
ZA843275B (en) * 1983-05-05 1984-12-24 Hoffmann La Roche Novel vectors for interferon expression
JPS61500586A (ja) * 1983-11-14 1986-04-03 チロン　コ−ポレイシヨン インタ−ロイキン−２産生のための方法及び組成物
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3500961A1 (de) * 1985-01-14 1986-07-17 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Escherichia-coli-staemme, dna-teilsequenzen dieser staemme und herstellungsverfahren
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
ZA877924B (en) * 1985-12-04 1987-08-26 Immunex Corp Cloning,characterization,and expression of bovine gamma interferon
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
DE3784650D1 (de) * 1986-12-12 1993-04-15 Ciba Geigy Ag Vorbeugende massnahmen zur verhinderung der "komplexen respiratorischen erkrankung bei rindern" durch verabreichung von interferon.
ATE120798T1 (de) * 1987-12-29 1995-04-15 Toray Industries Synthetisches plasmid, transformierte zelle, katzen-interferon-gen und verfahren zur herstellung von katzen-interferon.
WO1989009065A1 (en) * 1988-03-23 1989-10-05 University Of Georgia Research Foundation, Inc. Large-scale production of bovine leukocyte interferon
CA2019803C (en) * 1989-06-29 2000-04-25 Akira Yanai Feline interferon and process for production thereof
US5641656A (en) * 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
KR20050053749A (ko) * 2002-10-08 2005-06-08 다우 아그로사이언시즈 엘엘씨 항바이러스제, 면역보강제 그리고 백신 촉진제의 생산과송달을 위해 수정된 재조합 세포들
CA2504267A1 (en) * 2002-11-18 2004-06-03 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CN109206502B (zh) * 2018-09-26 2022-03-04 东北农业大学 一种猫干扰素ω及其制备方法和在抗病毒中的应用
CN112457391B (zh) * 2020-11-02 2022-10-04 天津大学 猪干扰素α、β、λ1在酿酒酵母中共分泌表达的方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ES498343A0 (es) * 1980-01-08 1983-09-01 Biogen Nv Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos.
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna

Also Published As

Publication number Publication date
JPH0948799A (ja) 1997-02-18
EP0088622A2 (en) 1983-09-14
DK171790B1 (da) 1997-05-26
DE3382789D1 (de) 1995-07-20
ES8500327A1 (es) 1984-11-01
PT76353A (en) 1983-04-01
DD207732A5 (de) 1984-03-14
AU1212283A (en) 1983-09-15
IE830471L (en) 1983-09-08
ES8605534A1 (es) 1986-04-01
JP2633510B2 (ja) 1997-07-23
DE3308030A1 (de) 1983-09-29
IL68059A (en) 1990-11-05
YU46722B (sh) 1994-04-05
AU572447B2 (en) 1988-05-12
FR2530662B1 (fr) 1985-11-15
JP2677759B2 (ja) 1997-11-17
DK111183A (da) 1983-09-09
IE54592B1 (en) 1989-12-06
ATE123813T1 (de) 1995-06-15
GB2116566A (en) 1983-09-28
GB8306225D0 (en) 1983-04-13
PT76353B (en) 1986-02-27
FR2530662A1 (fr) 1984-01-27
NZ203493A (en) 1987-08-31
JPH06315385A (ja) 1994-11-15
YU55583A (en) 1986-04-30
JPS58224690A (ja) 1983-12-27
DK111183D0 (da) 1983-03-07
PL153902B1 (en) 1991-06-28
DE3308030C2 (de) 1996-03-28
DE3382789T2 (de) 1995-12-14
EP0088622A3 (en) 1984-08-01
JPH08187088A (ja) 1996-07-23
GB2116566B (en) 1985-11-27
PL240926A1 (en) 1983-10-24
CA1339936C (en) 1998-06-30
JP2633227B2 (ja) 1997-07-23
JP2721139B2 (ja) 1998-03-04
EP0088622B1 (en) 1995-06-14
ES533485A0 (es) 1986-04-01
IL68059A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
ES520358A0 (es) Procedimiento para producir polipeptido
FI20000025A (fi) Menetelmä hemoglobiinin kaltainen yhdistelmäproteiinin valmistamiseksi
GR3021198T3 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
FI103987B1 (fi) Interleukiini-7
JPS55131399A (en) Cultivation of namalva cell and replacing animal serum protein by human albumine for producing interferon by said cell